Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology... see more

TSX:CPH - Post Discussion

View:
Post by Stocker46 on Mar 09, 2021 3:52pm

Quiet Board

Very interested in seeing Cipher's 4th Quarter/Annual Financials that will likely be released next week.

Highly probable they booked the $5.4M US impairment charge in 4th quarter while the $240,000 (plus any other payments to Bausch prior to March 31st) will be booked in 1st Quarter.

Cipher may generate enough revenue & product profits (in 4th Q)
to offset a significant chunk of the impairment charge .. but it's doutful.
I'd guesstimate they'll record a Net Loss for the year 2020.
Comment by GJS471 on Mar 12, 2021 1:50pm
In some ways, the quiet board is a nice change.   Lately there has been lots of questionable opinions, lopsided analysis and only occassionally something of value.   In any case, I agree with most of your comments, including that Q4 is toast with the impairment charge.  But I do not think the charge will wipe out the whole year profits.  None the less it will not do ...more  
Comment by maxxie3 on Mar 12, 2021 3:35pm
It is a non cash charge so it would not impact cash flow it would reduce the net earnings it will be interesting to see how the market see it. I think everyone dump shares already.
Comment by Stocker46 on Mar 14, 2021 12:57pm
Correct, the impairment charge is a non-cash entry. It's kind of like spending  $8 - $ 9 million on a fixed asset to be amortized over 15 or 20 years. Then you find out a year & a half later that it's totally useless and are forced to write it off ... and that you'll be required to pay an undetermined amount of cash to get rid of it.
Comment by stockfy on Mar 15, 2021 5:12am
Look Stocker46, you are not the smart of the board. We do not need your confirmation. We do know that it's correct. We do know that it's a non-cash impairment charge although the clueless Pabaloo alias is trying to make a case. Pabaloo alias has serious spelling problems but he thinks he can provide us with his investment advice!  CPH has also stated it in its press release. It' ...more  
Comment by faraj69 on Mar 15, 2021 8:17am
Lmao Pablo has been a CPH advocate for years. Guy knows more about the company than anyone on this bb. There's NO DEMAND for this stock even with a low share float of 21 mill. 
Comment by r0nald on Mar 15, 2021 8:21am
I really don't like having lost an arbitration case that we couldn't loose. But really dislike not knowing how much we're going to have to pay Bausch. What if they want compensation for an at least one year delay in the Trulence launch? Compensation for lost revenues and profits? This could become quite an ugly affair.
Comment by Stocker46 on Mar 15, 2021 11:10am
NEWS FLASH stockfy - the idea of investing in the stock market is to buy low & sell high. Already stated I believe the SP could go significantly higher. Unfortunately, this Trulance fiasco is a big deal. It will not only wipe out all or a major portion of 2020 earnings, but will also affect 2021 earnings. Problem is we have no idea by how much. Hopefully, their upcoming conference call will ...more  
Comment by stockfy on Mar 15, 2021 11:56am
Stocker46, I know it hurts. It hurts a lot. I'm sorry my friend. I'm sorry that you bought CPH above C$10 a few years ago and you sold it well below C$10, according to your own previous statements. So I'm sorry that you recorded such a big loss. As a result, you are now a desperate hater who regularly twists the truth, makes misleading comments and posts unfounded speculation ...more  
Comment by Stocker46 on Mar 15, 2021 1:12pm
You're just a little delusional stockfy. I had never heard of Cipher before you were pumping it on the CZO board. I've never posted on this board until a few weeks ago. Seems like you're the one who's desperate to get the SP higher. If I get the right price I'll buy in .. if not, I'll move on & invest elsewhere .. no big deal.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities